All Stories

  1. Fresh frozen plasma for cardiovascular surgery
  2. Transfusion of fresher versus older red blood cells for all conditions
  3. Red blood cell transfusion for people undergoing hip fracture surgery
  4. Transfusion Interventions in Critical Bleeding Requiring Massive Transfusion: A Systematic Review
  5. The Impact of Electronic Decision Support on Transfusion Practice: A Systematic Review
  6. Restrictive versus liberal red blood cell transfusion strategies for patients with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support
  7. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
  8. Red cell transfusion management for patients undergoing cardiac surgery for congenital heart disease
  9. Transfusion of fresher versus older red blood cells for all conditions
  10. Does bleeding affect patient‐reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review
  11. Interventions to Reduce Wrong Blood in Tube Errors in Transfusion: A Systematic Review
  12. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia
  13. Oral deferiprone for iron chelation in people with thalassaemia
  14. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
  15. Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in patients without haemophilia
  16. Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis
  17. Pathogen-reduced platelets for the prevention of bleeding
  18. Getting the Most Out of the Evidence for Transfusion Medicine
  19. What Is the Maximum Time That a Unit of Red Blood Cells Can Be Safely Left Out of Controlled Temperature Storage?
  20. Long-Term Effects of Autologous Bone Marrow Stem Cell Treatment in Acute Myocardial Infarction: Factors That May Influence Outcomes
  21. Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
  22. Red blood cell transfusion for people undergoing hip fracture surgery
  23. Red cell transfusion management for patients undergoing cardiac surgery for congenital heart disease
  24. Stem cell treatment for acute myocardial infarction
  25. Oral or parental iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
  26. Blood substitutes for avoiding allogeneic blood transfusion
  27. Antenatal interventions for fetomaternal alloimmune thrombocytopenia
  28. Pathogen-reduced platelets for the prevention of bleeding
  29. The Clinical Effects of Red Blood Cell Transfusions: An Overview of the Randomized Controlled Trials Evidence Base
  30. Where are the Systematic Reviews in Transfusion Medicine? A Study of the Transfusion Evidence Base
  31. Red cell transfusion for the management of upper gastrointestinal haemorrhage
  32. Processed versus fresh frozen bone for impaction bone grafting in revision hip arthroplasty
  33. Stem cell donation - What advice can be given to the donor?
  34. Quality of life and use of red cell transfusion in patients with myelodysplastic syndromes. A systematic review
  35. Route of delivery and baseline left ventricular ejection fraction, key factors of bone‐marrow‐derived cell therapy for ischaemic heart disease
  36. Stem cell therapy for ischaemic heart disease and congestive heart failure
  37. Red cell transfusion for the management of upper gastrointestinal haemorrhage
  38. Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors
  39. Stem cell treatment for acute myocardial infarction
  40. Blood transfusion administration—one- or two-person checks: which is the safest method?
  41. Oral deferiprone for iron chelation in people with thalassaemia
  42. Red cell transfusion for the management of upper gastrointestinal haemorrhage
  43. Processed versus fresh frozen bone for impaction bone grafting in revision hip arthroplasty
  44. Evidence-Based Use of Platelets1
  45. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia
  46. Putting clinical trials into context
  47. Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction
  48. Antenatal interventions for fetomaternal alloimmune thrombocytopenia
  49. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation
  50. Blood substitutes for avoiding allogeneic blood transfusion
  51. Platelet activation via the collagen receptor GPVI is not altered in platelets from chronic myeloid leukaemia patients despite the presence of the constitutively phosphorylated adapter protein CrkL
  52. Getting the Most out of the Evidence for Transfusion Medicine
  53. Getting the most out of the Evidence for Transfusion Medicine